EFTA01449662.pdf

SOUTHERN FINANCIAL, 1.I.0 ACCT. For the Period 8/1/13 to S/31/13 Note Unrealized Gain Loss is shown as "N. A" in cases where we do not have appropriate cost information for all tax lots comprising the position Please contact your J P Morgan learn (or additional information. Equity Detail Adjusted Cost Unrealized Est. Annual Inc. Price Quantity Value Original Cost GalnA.oss Accruec —liW7 Yield US Large Cap Equity ARIAD PHARMACEUTICALS INC 18.60 16.535 000 307,551.00 290,997.40 16,553.60 04033A-10-0 ARIA BIOGEN IDEC INC 213.02 2,099.000 448,276.90 250,454.95 199,821.95 09062X-104 BNB FACEBOOK 1NC-A 41.29 17,500.000 722,645.00 665,000.00 67,645.00 30303M-10-2 FB GENERAL ELECTRIC CO 23.14 23,000.000 532,220.00 496,109.06 36,110.92 17,480.00 3.28% 369604-10-3 GE JPM VALUE ADVANTAGE FD -INSIL 24.96 78,709.170 1.964.580.88 2,000,000.00 (35,419.12) 19,992.12 1.02% FUND 1400 4812A2-58-7 JVAI X Total US Large Cap Equity 53,973,273.78 53,702,561.43 $270,712.36 937,472.12 0.94% US Small/Mid Cap Equity DEUTSCHE 8K AG LDN BRH 8.90 50,000.000 445800 00 352.529.00 92,471.00 DBL LONG ETN38 25154H-55-8 DAG J.P Morgan Accounnage 5 of 48 Consolidated Statement Page 8 CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0 105116 CONFIDENTIAL SDNY_GM_00251300 EFTA01449662